Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Key Takeaways Retatrutide is a triple agonist binding GIP, GLP-1 and glucagon receptors simultaneously, a mechanism absent from all MHRA-authorised incretin therapies The 32mg pen format minimises wastage in early-phase protocols and supports typical titration schedules from 0.5mg to 4mg per administration Every unit ships with batch-level traceability, HPLC purity documentation and a certificate of analysis Retatrutide holds no MHRA marketing authorisation and is supplied strictly for laboratory research use UK orders ship free via tracked Royal Mail within 13 working days
They are reported here for research-reference purposes only and do not constitute administration recommendations of any kind
GLP-1RAs have demonstrated encouraging positive benefits on bone strength and quality
Work with your doctor and even a nutritionist or dietitian to ensure youre getting enough protein and nutrients
The two therapies work in tandem: one purifies at the cellular level, the other clears the pathways that carry waste away
Weeks 13 to 16: 7.5 mg to 5 mg
US$ 24.56
US$ 21.55
US$ 22.30
US$ 28.95
US$ 27.13
US$ 20.43
